Evidence mapPaperPMID 41399393Full record

ArticleAtherosclerosis plus2025

Neural network model outperforms conventional equations in LDL cholesterol estimation: A comparative study of 188,887 Chinese individuals with focus on hypertriglyceridemia.

Hao Xue, Yu Lin, Youlin Liu, Lin Li, Pengzhen Chen, Mingyang Li, Ling Ji, Yong Xia

Erratum issuedAbstract read
In one paragraph

Article in Atherosclerosis plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Hao XueDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Yu LinDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Youlin LiuShenzhen Mindray Bio-Medical Electronics Co.,Ltd, China.
Lin LiShenzhen Mindray Bio-Medical Electronics Co.,Ltd, China.
Pengzhen ChenShenzhen Mindray Bio-Medical Electronics Co.,Ltd, China.
Mingyang LiDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Ling JiDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Yong XiaDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate estimation of low-density lipoprotein cholesterol (LDL-C) is crucial for atherosclerotic cardiovascular disease (ASCVD) risk management. Extensive international validation studies have demonstrated that traditional formulas (Friedewald, Martin/Hopkins, Sampson) often yield significant errors under conditions of extreme hypertriglyceridemia. This study aimed to assess the performance of these conventional formulas in Chinese populations and develop a novel neural network-based LDL-C estimation model [LDL-C(NN)]. Methods: In this retrospective study, we analyzed 188,887 lipid profiles-including total cholesterol, triglycerides, high-density lipoprotein cholesterol, and directly measured LDL-C-from Peking University Shenzhen Hospital using Mindray (outpatients, n = 83,731) and Beckman (inpatients, n = 105,156) systems. The test results from the two detection systems are non-overlapping. We used stratified random sampling based on TG levels to select 30,000 profiles from each of the two systems as the training dataset (60,000 profiles in total). Within this training dataset, 70 % of profiles were used for parameter learning, 15 % were used for early-stopping validation, and 15 % were used for post-training testing. The remaining profiles constituted the independent test set for the final performance evaluation (Mindray: n = 53,731; Beckman: n = 75,156). We then compared the performance of LDL-C(NN) with the Friedewald, Martin/Hopkins, and Sampson formulas using correlation coefficient (r), root mean square error (RMSE), Concordance Correlation Coefficient (CCC) and clinical risk stratification accuracy. Results: Compared with directly measured LDL-C, LDL-C(NN) demonstrated higher correlation and lower RMSE than other traditional LDL-C equations in the Mindray system (r = 0.9778, RMSE = 0.1762 mmol/L; vs Friedewald quation: r = 0.8894, RMSE = 0.4783 mmol/L; vs Martin/Hopkins quation: r = 0.9658, RMSE = 0.2463 mmol/L; vs Sampson quation: r = 0.9548, RMSE = 0.2934 mmol/L, particularly patients with high triglycerides (TG levels, 9.03-13.56 mmol/L, neural network Model: CCC = 0.8750, vs Friedewald quation: CCC = 0.3320; vs Martin/Hopkins quation: CCC = 0.7278; vs Sampson quation: CCC = 0.4176). Beckman database shows the same performance. The clinical classification accuracy for LDL-C(NN) reached 87.5 % (Mindray) and 83.4 % (Beckman), surpassing that of other traditional LDL-C equations (66.6-78.7 %). Conclusions: By overcoming the linear assumptions of conventional equations, the neural network-based model significantly improves LDL-C estimation in hypertriglyceridemia (especially≥9.03 mmol/L) and complex lipid profiles, thereby expanding the applicability of traditional formulas, while demonstrating robust performance across multiple analytical systems.

Indexed as

Clinical decisionFriedewald equationHypertriglyceridemiaLow-density lipoprotein cholesterolNeural network

Identifiers

PMID41399393
PMCPMC12702375

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.